118.54GBP+1.49%Mkt Cap: 364.66M $P/E: —Today
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap364.66M $
Enterprise Value246.85M $
Revenue (TTM)5.98M $
Gross Profit-66.43M $
Net Income (TTM)-140.75M $
Revenue/Share0.0244 USD
Last Price118.54 GBP
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees90
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.99
PEG—
EV/EBITDA-1.99
EV/Revenue41.31
P/S61.02
P/B1.22
EPS (TTM)-0.34
EPS (Forward)-0.29
52W Range
113.0069% of range121.00
52W High121.00 GBP
52W Low113.00 GBP
Profitability
Gross Margin0.00%
Oper. Margin-1797.79%
EBITDA Margin0.00%
Profit Margin-2355.42%
ROE-35.16%
ROA-20.52%
Growth
Revenue Growth-38.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-109.19M $
CapEx (TTM)7.70K $
FCF Margin-1931.54%
FCF Yield-31.65%
Net Debt-109.61M $
Net Debt/EBITDA0.88
Balance Sheet
Debt/Equity0.06
Current Ratio6.59
Quick Ratio6.41
Book Value/Sh0.9570 GBP
Cash/Share1.186 GBP
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBP
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)356.22 GBP
Upside (mean)+200.5%
Target Range228.62 GBP – 494.20 GBP
GBP228.62+200.5% to meanGBP494.20
# Analysts3
Ownership
Shares Out.243.42M
Float156.80M
Insiders10.05%
Institutions52.19%
Technical
SMA 50124.04 (-4.4%)
SMA 200125.71 (-5.7%)
Beta0.77
S&P 52W Chg18.16%
Avg Vol (30d)450.02K
Avg Vol (10d)805.19K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—